Lipocine Inc. Insider Trading

LPCN

⊜ Compare

Last 12 months

Insiders bought 517K on the open market and sold nothing.

Net open-market

+517K

6 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Sep 2026

Sep 30, 2026

Get an email when LPCN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 29 – 30	John W. Higuchi Director	Bought 2 parts	25,007	$2.20 average	55K	12%	Form 4
Sep 28	John W. Higuchi Director	Bought	12,561	$2.16	27K	6.2%	Form 4
Apr 7	John W. Higuchi Director	Bought	40,000	$2.03	81K	24%	Form 4
Apr 6	John W. Higuchi Director	Bought	123,000	$2.05	252K	301%	Form 4
Apr 6	Mahesh V. Patel Chief Executive Officer	Bought	25,000	$2.03	51K	18%	Form 4
Apr 2	Mahesh V. Patel Chief Executive Officer	Bought	25,000	$2.02	51K	23%	Form 4

Sep 29 – 30
John W. Higuchi
Director · bought 25,007 at avg $2.20
55K
12% of stake
Sep 28
John W. Higuchi
Director · bought 12,561 at $2.16
27K
6.2% of stake
Apr 7
John W. Higuchi
Director · bought 40,000 at $2.03
81K
24% of stake
Apr 6
John W. Higuchi
Director · bought 123,000 at $2.05
252K
301% of stake
Apr 6
Mahesh V. Patel
Chief Executive Officer · bought 25,000 at $2.03
51K
18% of stake
Apr 2
Mahesh V. Patel
Chief Executive Officer · bought 25,000 at $2.02
51K
23% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LPCN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LPCN

CompareIntrinsic value

OVIDOvid Therapeutics Inc.

$2.74+14.17%25

RNACCartesian Therapeutics Inc.

$6.84+6.71%10

CPMDCannapharmaRx Inc.

$0.00+0.00%0

BSPKBespoke Extracts Inc.

$0.00+0.00%30

SCPXScorpius Holdings Inc.

$0.00+0.00%10

ATXIAvenue Therapeutics Inc.

$0.40+0.00%10

HYPDHyperion DeFi, Inc.

$3.23+5.74%25

DAREDare Bioscience Inc.

$0.66+1.83%10

Spot a number that looks wrong? Check it in LPCN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LPCN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.